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 Obesity is increasing nowadays including in children and there is lack of 
information on the pathophysiology and their complication such as insulin 
resistance and dyslipidemia. This study was aimed to investigate the 
comparison of lipid profile in obese children with and without insulin 
resistance. A crossectional study held at an elementary school in Denpasar, Bali 
from August until September 2015. Independent t-test, Mann-Whitney test, and 
Multivariate analysis of covariance (MANCOVA) were performed to compare 
lipid profile in obese children with and without insulin resistance. A P-value 
less than 0.05 was considered statistically significant. A total of 50 obese 
children were analyzed. In this study, we found 12 subjects (24%) with insulin 
resistance. Nonsignificant associations were found between insulin resistance 
with total cholesterol, HDL, LDL, and ratio of HDL/LDL. A significant association 
was found between insulin resistance and triglyceride level after adjusted age 
and sex. There was a significant mean difference of triglycerides in the insulin 
resistance and noninsulin resistance groups in obese children. 
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1.  Introduction 
The prevalence of childhood obesity in the world has increased dramatically over the past three 
decades and is considered by World Health Organization (WHO) to be one of the most serious public 
health problems of the 21st century.[1-3] Worldwide, the prevalence of overweight and obesity has 
increased among children and adolescents in developing countries, reached 8.1% (7.7–8.6) to 12.9% 
(12.3–13.5) in 2013 for boys and 8.4% (8.1–8.8) to 13.4% (13.0–13.9) in girls.[1] Data from the United 
States shows that 17% of children are obese.[2] Prevalence of childhood obesity in Indonesia is 19.7% in 
boy and 32.9% in a girl.[4] 
The presence of obesity is associated with significant adverse effects on health including metabolic, 
endocrinology, cardiovascular, gastrointestinal, pulmonary, neurologic, psychiatric, hematologic, and 
skeletal complications, and development of some types of malignancies. All of these unfavorable effects 
lead up to a shortened lifespan. Studies strongly suggest that vascular, histopathological and metabolic 
changes begin in the childhood period. Development of metabolic complications associated with obesity 
during childhood track into adulthood and increases the risk for type 2 diabetes, dyslipidemia, and early 
cardiovascular disease.[5] 
Symptoms of dyslipidemia usually appear in the fourth decade of life, but the development of 
atherosclerosis is known to begin at earlier ages and related to dyslipidemia.  In autopsy studies, fatty lines 
which are early sign of atherosclerosis can be found even at the age of 2 years old and proportional to body 
mass index (BMI), serum total cholesterol (TC), trygliceride (TG), low density lipoprotein (LDL), and 
inversely proportional to high density lipoprotein (HDL). Insulin resistance (IR) that is commonly found in 
obese adult as a component of metabolic syndrome usually persists in normoglycemia or hyperglycemia 
subjects.[6] 
Recent studies suggest that there is a correlation between IR and high lipid level and lipoprotein. 
Visceral fat that closed to hepatic portal vasculature is responsible for the positive association between 
dyslipidemia, hyperinsulinemia, and glucose intolerance. Both, hyperlipidemia and insulin resistance are 
related to cardiovascular disease and type 2 diabetes mellitus in the adult.[7-10] Until recently, there are 
no studies about IR in obese children in Indonesia. Correlation of IR and dyslipidemia in obese children is 
unclear. The objective of this study was to comparative lipid profile in obese children with or without 
insulin resistance. 
 
2.  Research Method 
This study was an analytic study using a cross-sectional design, held at Nutrition and Metabolic Disease 
Sub Division, Department of Child Health, Medical School, Udayana University, Denpasar. Study subjects 
were obese elementary school children in elementary school V, VI, and Cipta Darma Denpasar during 
August until September 2015. Eligible patients were chosen by consecutive sampling method. The sample 
size was counted by single proportion formula with  0.05 and precision 10%. Based on the previous study 
by Riskerdas the proportion of obese children in Indonesia is 32.9%, this will lead to minimum estimated 
sample size of 50 subjects. This study was performed after obtaining permission from Ethics Committee of 
Medical School, Sanglah Hospital, Denpasar. The inclusion criteria were children aged 6 to 11 years old 
that diagnosed as obese during anthropometry screening. The exclusion criteria were patients with 
malignancy, having steroid therapy, having diabetes therapy, or parents refused to sign written informed 
consent. Independent t-test and Mann-Whitney test were performed to compare lipid profile in obese 
children with and without insulin resistance. A P-value less than 0.05 was considered statistically 
significant. 
 
3.  Results and Analysis 
A total of 50 children were studied from August to September 2015. There were no subjects that 
excluded from the study. Among subjects 33 (66%) were boys and 17 (39%) were girls, giving a male: 
female ratio of 2: 1. All subjects were obese children according to WHO criteria. All subjects had normal 
blood fasting glucose, all subjects were having normal lipid profiles and none of them showed clinical signs 
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like acanthosis nigricans, skin tags, striae, acne, or hirsutism. There were 12 (24%) children diagnosed 
with insulin resistance, most of them were boys (67%). Characteristics of subjects were shown in Table 1. 
 
Table 1  
Subjects Characteristics 
 
Variables RI (N=12) Non RI (N=38) Total 
Sex, male, n (%) 8 (66.67%) 25 (65.79%) 33 (66%) 
Age (years), mean (SD) 10.07 (1.31) 8.64 (1.40) 8.98 (1.49) 
BMI for Age  (z score), mean (SD) 3.30 (0.92) 2.93(0.73) 3.02 (0.78) 
Total cholesterol (mg/dL), mean (SD) 168.83 (27.37) 160.26 (27.56) 162.32 (27.48) 
LDL cholesterol (mg/dL), mean (SD) 106.17 (23.98) 102..13 (24.30) 103.10 (24.04) 
HDL cholesterol (mg/dL), mean (SD) 41.00 (6.90) 43.95 (8.32) 43.24 (8.03) 
Triglyceride (mg/dL), mean (SD) 156.42 (94.96) 92.92 (45.62) 108.16 (65.92) 
 
Bivariate analysis is performed using an independent t-test to analyze the association of total 
cholesterol, HDL, LDL, and the ratio of HDL/LDL with insulin resistance due to a normal distribution, while 
triglyceride association with insulin resistance was analyzed using Mann-Whitney test due to abnormal 
distribution (Table 2). There was no significant association between total cholesterol, HDL, LDL, and the 
ratio of HDL/LDL level with insulin resistance found in our study, but there was a significant association 
between triglyceride and insulin resistance.  
 
Table 2  
Bivariate Analysis for Profile Lipid and Insulin Resistance 
 
Variable Group Level Mean difference 
(95% CI) 
P 
Total cholesterol (mg/dL), mean 
(SD) 
IR 
Non IR 
168.83 (27.37) 
160.26 (27.56) 
8.57 
(-10.6 to 27.6) 
0.357* 
Triglyceride (mg/dL), median  
(min-max) 
IR 121.00 (46.00-338.00) - 0.036** 
Non-IR 83.00 (46.00-227.00) -  
LDL (mg/dL), mean (SD) IR 
Non IR 
106.17 (23.98) 
102.13 (2.43) 
4.03 
(-12.65 to 20.72 ) 
0.618* 
HDL (mg/dL), mean (SD) IR 
Non IR 
41.00 (6.90) 
43.95 (1.05) 
2.94 
(-7.94 to 2.04) 
0.234* 
Ratio of total chol:LDL, mean (SD) IR 
Non IR 
4.23 (1.05) 
3.74 (0.82) 
0.48 
(-0.2 to 1.18) 
0.167* 
n: number, SD: standard deviation, CI: confidence interval, *independent t-test, **Mann-Whitney test 
 
We found consistent results there was a significant  different level of  triglyceride in obese children  with 
and without insulin  resistance after  adjusted by using multivariate  analysis of  covariance (MANCOVA) 
with p = 0.003 
Obesity in children has reached alarming proportions in the United States. Increasing overweight and 
obesity has been noted since surveys were begun in 1963, but the rate of increase has been accelerating 
over the last 2 decades.[6] The prevalence of childhood obesity has nearly tripled since the 1970s and is 
recognized as a serious public health concern.[11] Obesity tends to track over time, and the increase in 
overweight among young children is of signiﬁcant concern.[12] The prevalence of obesity in children has 
reported an increase from 4.2% in 1990 to 6.7% in 2010 and is estimated to be 9.1% in 2020, while in 
Denpasar prevalence increase from 11% in 2002 to 21.7% in 2010.[13] A study in 2013 in primary school 
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children shows the prevalence of obesity is 15% in Denpasar, 21% in urban areas and 5% in rural 
areas.[14] 
Pediatric obesity is related to an increased risk of metabolic alterations such as inflammation, insulin 
resistance, glucose intolerance, and hepatic steatosis, as well as to established pathological conditions such 
as nonalcoholic fatty liver disease, metabolic syndrome, type 2 diabetes, and cardiovascular disease, either 
at the time or later in life. The scientific evidence demonstrated that chronic low-grade inflammation is the 
link between obesity and insulin resistance; the main mechanism involved is an increased synthesis of 
cytokines in adipose tissue and the resident macrophages, which interfere with insulin course and with the 
expression of genes involved in insulin performance. That inflammation and insulin resistance is the 
underlying cause of most the pathological complications and obesity-related comorbidities.[8,10] Obesity 
condition is marked with IL-6, CRP, TNF-α increase with adiponectin and IL-10 decrease that lead into a 
proinflammation condition that ends as insulin resistance and endothelial dysfunction.[15] An animal 
study showed that insulin signal abnormality apparently is the main key to insulin resistance.[16], [31] 
Insulin resistance can be diagnosed through several examinations, such fasting glucose test, oral 
glucose tolerance test, intra vena glucose tolerance test, and insulin level examination. The gold standard 
for diagnosis is hyperinsulinemic-euglycemic clamp and intra vena glucose tolerance test, but these tests 
are expensive and invasive and not recommended for large epidemiologic study. Diagnosis method that 
recommended for the epidemiologic study is homeostasis model assessment of insulin resistance (HOMA-
IR).[17] In this study, we performed HOMA-IR method to assessed insulin resistance. HOMA-IR can predict 
insulin resistance from fasting glucose and insulin level. Limitation of this examination is until recently 
there is no gold standard for cut-off point of diagnosis. Study in America found cut-off point was 3.16 
(sensitivity 76%, specificity 66%)[18], study in Chili found 2.6 (sensitivity 59%, specificity 87%)[19], study 
in China found 2.6 (sensitivity 78%, specificity 67%)[20], study in India found 2.5 (sensitivity >70%, 
specificity >60%)[21], In this study we used cut off point 2.6 for diagnosing insulin resistance. [32] 
In this study, we conducted a study that assessed children with obese aged 6-11 years old. As shown in 
Table 1, most of our subjects were boys, this was in opposition with Survei Sosial Ekonomi Nasional 
(Susenas) data which find that there is 4.6% boy and 8% girl obese in urban areas in Indonesia.[13] In our 
study, insulin resistance was higher in male subjects compared to female subjects (66.67% vs 33.33%, 
respectively).This result similar to another study that showed male subjects are more susceptible to 
insulin resistance. This might be related to estrogen in female subjects as protector factor for insulin 
resistance.[22], [33] 
In this study we found that there were 12 subjects had IR (24%) with normal blood sugar. This result is 
lower compared to the worldwide published number (50-70%)[23] but similar with study in British that 
showed insulin resistance prevalence was 30% in children under 12 years old in 2003.[24] Obesity is 
strongly related to cardiovascular disease and insulin resistance in normoglycemia or types 2 diabetes 
adult subjects in one study. Cardiovascular disease is increasing in accordance with body weight increase. 
It is apparently due to the strong relationship between adipose tissue and insulin resistance. Body weight 
reduction also related to insulin decrease and insulin sensitivity increase.[25] This result is in accordance 
with most studies in children that showed a majority of persons with IR will not develop type 2 diabetes 
even if IR is strongly related to type 2 diabetes and cardiovascular disorder in later life. There is a genetic 
background that strongly influences the adequacy of pancreatic β-cell function, and this is influenced by 
the human leukocyte antigen haplotype. Individual with IR that can compensate trough hyperinsulinemia 
may escape diabetes but still prone to other complications such early atherosclerosis, hypertension, 
hypercoagulation, dyslipidemia, fatty liver, and also malignancy. This make IR condition is not benign even 
if no diabetes or high blood sugar found.[26] 
In this study, we found that all subjects had normal TC, LDL, HDL, and TG. Obesity has a negative impact 
on glucose/insulin axis and lipid metabolism. Insulin secretion rate is significantly increased in obese 
compared to a normal adult, but there were no differences in insulin clearance or hepatic insulin clearance. 
Abnormality on glucose metabolism is found very early on obese children, that showed insulin response on 
food stimulus and maximal glucose uptake is decreased according to higher age and duration of obesity. It 
can be concluded that first negative impact of obesity is insulin resistance. This explained there was 24% 
subject to insulin resistance with normal lipid profile since we performed a study on early age. This study 
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is similar to study in Czech children that found a high incidence of IR in obese children. Dyslipidemia only 
found in older children in their study (9-17 years) and IR found in 53% obese subjects.[25-28] 
In this study, we found that there was no significant association between TC, LDL, HDL, and ratio of 
HDL/LDL with IR, but there was a significant association with trygliceride. These results are similar to 
another study in adults that showed the relation of IR and trygliceride and cardiac heart disease events in 
later life (14 years follow up) but not with total cholesterol. Insulin resistance apparently has a direct 
effect on cardiovascular events with or without hyperlipidemia.[28] Another study in Italy found that HDL 
and triglyceride correlated with IR, but not with total cholesterol and LDL.[29] In obese subjects, there is 
evidence that suggests an association of insulin resistance and hepatic accumulation of fat. This is related 
to a reduced effect of insulin action on adipose tissue that will reduce lipolysis and increased the flux of 
free fatty acid to the liver. This effect, together with hepatic lipogenesis due to hyperinsulinemia is 
responsible for triglyceride accumulation in the hepatocytes.[30] 
Limitation of the present study is we did not analyze birth weight, pubertal stage, or thyroid status that 
can contribute to insulin status. We did not gain any information about the metabolic syndrome that 
strongly related to IR.  
 
4.  Conclusion 
Recent studies showed that IR was not associated with cholesterol but significantly associated with 
triglyceride level in obese children. More studies are needed to explore the causality of these relationships. 
Furthermore, future research needs larger samples and should focus on the association of IR with 
dyslipidemia and metabolic syndrome and also their relationship to visceral or peripherals fat. 
 
Competing interests: None 
 
Funding: Individually 
 
Acknowledgments 
The authors would like thanks the editors of the health sciences for their valuable time and advice. Thus, 
the article has been published. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          e-ISSN: 2550-696X  p-ISSN: 2550-6978 
IJHS   Vol. 2 No. 2, August 2018, pages: 9~17 
14
References 
1. Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., ... & Abraham, J. P. (2014). Global, 
regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a 
systematic analysis for the Global Burden of Disease Study 2013. The lancet, 384(9945), 766-781.  
View in (Google Scholar) 
 
2. Ogden, C. L., Carroll, M. D., Kit, B. K., & Flegal, K. M. (2014). Prevalence of childhood and adult obesity in the 
United States, 2011-2012. Jama, 311(8), 806-814.  
View in (Google Scholar) 
 
3. Williams, J., Scarborough, P., Matthews, A., Cowburn, G., Foster, C., Roberts, N., & Rayner, M. (2014). A 
systematic review of the influence of the retail food environment around schools on obesity‐related 
outcomes. Obesity reviews, 15(5), 359-374.  
View in (Google Scholar) 
 
4. Kesehatan, D., & RI, K. K. (2013). Riset kesehatan dasar. Jakarta: Badan Penelitian dan Pengembangan 
Kesehatan Departemen Kesehatan Republik Indonesia.  
View in (Google Scholar) 
 
5. Arslan, N., Erdur, B., & Aydin, A. (2010). Hormones and cytokines in childhood obesity. Indian 
pediatrics, 47(10), 829-839.  
View in (Google Scholar) 
 
6. García, O. P. (2012). Effect of vitamin A deficiency on the immune response in obesity. Proceedings of the 
Nutrition Society, 71(2), 290-297.  
View in (Google Scholar) 
 
7. Nicklas, T. A., Baranowski, T., Cullen, K. W., & Berenson, G. (2001). Eating patterns, dietary quality and 
obesity. Journal of the American College of Nutrition, 20(6), 599-608.  
View in (Google Scholar) 
 
8. Gahagan, S. (2011). Overweight and obesity. Kliegman RM, Stanton BF, Behrman RE, Geme JWS, Schor NF. 
Nelson textbook of pediatrics. 19th ed. Philadelphia: Elsevier/Saunders, 179-188.  
View in (Google Scholar) 
 
9. Birch, L. L., & Fisher, J. O. (1998). Development of eating behaviors among children and 
adolescents. Pediatrics, 101(Supplement 2), 539-549.  
View in (Google Scholar) 
 
10. López-Alarcón, M., Perichart-Perera, O., Flores-Huerta, S., Inda-Icaza, P., Rodríguez-Cruz, M., Armenta-
Álvarez, A., ... & Mayorga-Ochoa, M. (2014). Excessive refined carbohydrates and scarce micronutrients 
intakes increase inflammatory mediators and insulin resistance in prepubertal and pubertal obese 
children independently of obesity. Mediators of inflammation, 2014.  
View in (Google Scholar) 
 
11. Slyper, A. H. (2004). The pediatric obesity epidemic: causes and controversies. The Journal of Clinical 
Endocrinology & Metabolism, 89(6), 2540-2547.  
View in (Google Scholar) 
 
12. O'Connor, T. M., Yang, S. J., & Nicklas, T. A. (2006). Beverage intake among preschool children and its effect 
on weight status. Pediatrics, 118(4), e1010-e1018.  
View in (Google Scholar) 
 
IJHS                         e-ISSN: 2550-696X  p-ISSN: 2550-6978    
Tjiang, N., & Sidiartha, I. (2018). Lipid profile in obese children with and without insulin resistance. International 
Journal Of Health Sciences (IJHS), 2(2), 9-17. 
doi:10.29332/ijhs.v2n2.110 
15 
13. Dewi, M. R., & Sidiartha, G. L. (2013). Prevalensi dan faktor risiko obesitas anak sekolah dasar di daerah 
urban dan rural. Medicina, 44(1).  
View in (Google Scholar) 
 
14. Yussac, M. A. A., Cahyadi, A., Putri, A. C., Dewi, A. S., Khomaini, A., Bardosono, S., & Suarthana, E. (2007). 
Prevalensi obesitas pada anak usia 4-6 tahun dan hubungannya dengan asupan serta pola makan. Majalah 
Kedokteran Indonesia, 57(2), 47-53.  
View in (Google Scholar) 
 
15. Bastard, J. P., Maachi, M., Lagathu, C., Kim, M. J., Caron, M., Vidal, H., ... & Feve, B. (2006). Recent advances in 
the relationship between obesity, inflammation, and insulin resistance. European cytokine network, 17(1), 
4-12.  
View in (Google Scholar)  
 
16. Saad, M. J., Araki, E., Miralpeix, M., Rothenberg, P. L., White, M. F., & Kahn, C. R. (1992). Regulation of insulin 
receptor substrate-1 in liver and muscle of animal models of insulin resistance. The Journal of clinical 
investigation, 90(5), 1839-1849.  
View in (Google Scholar) 
 
17. Lee, J. M., Okumura, M. J., Davis, M. M., Herman, W. H., & Gurney, J. G. (2006). Prevalence and determinants 
of insulin resistance among US adolescents: a population-based study. Diabetes care, 29(11), 2427-2432.  
View in (Google Scholar) 
 
18. Keskin, M., Kurtoglu, S., Kendirci, M., Atabek, M. E., & Yazici, C. (2005). Homeostasis model assessment is 
more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for 
assessing insulin resistance among obese children and adolescents. Pediatrics, 115(4), e500-e503.  
View in (Google Scholar) 
 
19. Burrows, R., Correa-Burrows, P., Reyes, M., Blanco, E., Albala, C., & Gahagan, S. (2015). Healthy Chilean 
adolescents with HOMA-IR≥ 2.6 have increased cardiometabolic risk: association with genetic, biological, 
and environmental factors. Journal of diabetes research, 2015.  
View in (Google Scholar) 
 
20. Yin, J., Li, M., Xu, L., Wang, Y., Cheng, H., Zhao, X., & Mi, J. (2013). Insulin resistance determined by 
Homeostasis Model Assessment (HOMA) and associations with metabolic syndrome among Chinese 
children and teenagers. Diabetology & metabolic syndrome, 5(1), 71.  
View in (Google Scholar) 
 
21. Singh, Y., Garg, M. K., Tandon, N., & Marwaha, R. K. (2013). A study of insulin resistance by HOMA-IR and its 
cut-off value to identify metabolic syndrome in urban Indian adolescents. Journal of clinical research in 
pediatric endocrinology, 5(4), 245.  
View in (Google Scholar) 
 
22. Moran, A., Jacobs, D. R., Steinberger, J., Steffen, L. M., Pankow, J. S., Hong, C. P., & Sinaiko, A. R. (2008). 
Changes in insulin resistance and cardiovascular risk during adolescence: establishment of differential risk 
in males and females. Circulation, 117(18), 2361-2368.  
View in (Google Scholar) 
 
 
23. Cruz, M. L., & Goran, M. I. (2004). The metabolic syndrome in children and adolescents. Current diabetes 
reports, 4(1), 53-62.  
View in (Google Scholar) 
          e-ISSN: 2550-696X  p-ISSN: 2550-6978 
IJHS   Vol. 2 No. 2, August 2018, pages: 9~17 
16
24. Viner, R. M., Segal, T. Y., Lichtarowicz-Krynska, E., & Hindmarsh, P. (2005). Prevalence of the insulin 
resistance syndrome in obesity. Archives of Disease in Childhood, 90(1), 10-14.  
View in (Google Scholar) 
 
25. Ten, S., & Maclaren, N. (2004). Insulin resistance syndrome in children. The Journal of Clinical 
Endocrinology & Metabolism, 89(6), 2526-2539.  
View in (Google Scholar) 
 
26. Steinberger, J., & Daniels, S. R. (2003). Obesity, insulin resistance, diabetes, and cardiovascular risk in 
children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and 
Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes 
Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation, 107(10), 1448-1453.  
View in (Google Scholar) 
 
27. Pastucha, D., Filipcikova, R., Horáková, D., Radová, L., Marinov, Z., Malincikova, J., ... & Dobiás, M. (2013). 
The incidence of metabolic syndrome in obese Czech children: the importance of early detection of insulin 
resistance using homeostatic indexes HOMA-IR and QUICKI. Physiological research, 62(3), 277.  
View in (Google Scholar) 
 
28. Robins, S. J., Lyass, A., Zachariah, J. P., Massaro, J. M., & Vasan, R. S. (2011). Insulin resistance and the 
relationship of a dyslipidemia to coronary heart disease: the Framingham Heart Study. Arteriosclerosis, 
thrombosis, and vascular biology, 31(5), 1208-1214.  
View in (Google Scholar) 
 
29. Klop, B., Elte, J. W. F., & Cabezas, M. C. (2013). Dyslipidemia in obesity: mechanisms and potential 
targets. Nutrients, 5(4), 1218-1240.  
View in (Google Scholar) 
 
30. Chiarelli, F., & Marcovecchio, M. L. (2008). Insulin resistance and obesity in childhood. European Journal of 
Endocrinology, 159(suppl 1), S67-S74.  
View in (Google Scholar) 
 
31. Billaiya, R., Jain, A., Agarwal, R., & Jain, P. (2017). Introduction about Child Health Status in 
India. International Journal of Health Sciences (IJHS), 1(1), 12-22.  
View in (Google Scholar) 
 
32. Agarwal, R., Jain, P., Ghosh, M. S., & Parihar, K. S. (2017). Importance of Primary Health Care in the 
Society. International Journal of Health Sciences (IJHS), 1(1), 6-11.  
View in (Google Scholar) 
 
33. Malaiya, S., Shrivastava, A., Prasad, G., & Jain, P. (2017). Impact of Medical Education Trend in Community 
Development. International Journal of Health Sciences (IJHS), 1(1), 23-27.  
View in (Google Scholar) 
 
 
 
 
 
 
 
 
 
 
IJHS                         e-ISSN: 2550-696X  p-ISSN: 2550-6978    
Tjiang, N., & Sidiartha, I. (2018). Lipid profile in obese children with and without insulin resistance. International 
Journal Of Health Sciences (IJHS), 2(2), 9-17. 
doi:10.29332/ijhs.v2n2.110 
17 
 
Biography of Authors 
 
  
 
 
dr. Novita Tjiang 
Date of birth: 12 November 1982 
Educational background: Resident in Department of Pediatrics, Medical Faculty, 
Udayana University  
Email: tj_cloud2@yahoo.com  
 
 
 
 
  
 
 
 
Dr. dr. I Gusti Lanang Sidiartha, Sp.A (K) 
Date of birth: Karangasem, 10 June 1962 
Position: Head of Division Nutrition and Metabolic Diseases 
    Department of Pediatrics, Medical Faculty, Udayana University  
Educational background: Consultant of Nutrition and Metabolic Diseases (2011) 
Previous publication:  
1. Sidiartha L, Bakta I, Wiryana I, Sutirtayasa I, Sjarif D. 2016. Dietary iron intake 
and serum Interleukin-6 levels of obese children with and without iron 
deficiency. Bali Med J, 5(2):148-51. 
2. Sidiartha L, Bakta I, Wiryana I, Sutirtayasa I, Sjarif D. 2017. Eicosapentaenoic 
acid and docosahexaenoic acid in fish oil capsule supplementation in obese 
children decreases serum interleukin-6 and hepcidin and improves iron status. 
Bali Med J, 6(1):97-101. 
3. Daisy S, Dyah KW, Sidiartha IGL, Suparyata IB, Hartawan NB. 2017. Prevalence 
and association of cost and hospital malnutrition in Pediatric Intensive Care 
Unit Sanglah Hospital during 2015. Crit Care Shock, 20:10-16. 
4. Cempaka PMVP, Sidiartha IGL. 2017. Waist circumference and insulin levels in 
obese children. Paediatr Indones, 57:194-7. 
5. Paryati PV, Sidiartha IGL, Windiani IGAT, Adnyana IGANS. 2017. Quality of life 
among obese and non-obese early adolescents. Paediatr Indones, 57:216-22. 
6. Suwitri NPE, Sidiartha IGL. Omega-6 and omega-3 fatty acid content ratio of 
commercial complementary foods. International Journal of Health Sciences 
(IJHS), v.2, n.1, p.21-8.            
 Email: lanangsidiartha@yahoo.com 
  
 
 
